Biocardiainc Stock Filter Stocks by Fundamentals
| BCDA Stock | USD 0.38 0.01 2.70% |
BiocardiaInc fundamentals help investors to digest information that contributes to BiocardiaInc's financial success or failures. It also enables traders to predict the movement of BiocardiaInc Stock. The fundamental analysis module provides a way to measure BiocardiaInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiocardiaInc stock.
BiocardiaInc | Shares Owned by Institutions |
BiocardiaInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of BiocardiaInc from analyzing BiocardiaInc's financial statements. These drivers represent accounts that assess BiocardiaInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BiocardiaInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 20.8M | 35.0M | 32.8M | 37.0M | 14.1M | 13.4M | |
| Enterprise Value | 16.3M | 14.2M | 21.8M | 31.3M | 14.3M | 13.6M |
BiocardiaInc Institutional Holders
Institutional Holdings refers to the ownership stake in BiocardiaInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BiocardiaInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BiocardiaInc's value.| Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 21.4 K | State Street Corporation | 2023-12-31 | 21 K | Northern Trust Corp | 2023-12-31 | 19.2 K | Hrt Financial Llc | 2023-12-31 | 18.3 K | Wedbush Morgan Securities Inc | 2023-12-31 | 15 K | Pingora Partners Llc | 2023-12-31 | 7.4 K | Bank Of America Corp | 2023-12-31 | 6.5 K | Global Retirement Partners, Llc. | 2023-12-31 | 6.2 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 450 | Cm Management, Llc | 2023-12-31 | 700 K | Vanguard Group Inc | 2023-12-31 | 650.8 K |
BiocardiaInc Fundamentals
| Return On Equity | -7.04 | ||||
| Return On Asset | -1.14 | ||||
| Operating Margin | (160.31) % | ||||
| Current Valuation | 10.05 M | ||||
| Shares Outstanding | 26.87 M | ||||
| Shares Owned By Insiders | 33.84 % | ||||
| Shares Owned By Institutions | 7.71 % | ||||
| Number Of Shares Shorted | 535.91 K | ||||
| Price To Earning | (11.00) X | ||||
| Price To Book | 10.67 X | ||||
| Price To Sales | 21.85 X | ||||
| Revenue | 477 K | ||||
| Gross Profit | (7.48 M) | ||||
| EBITDA | (11.23 M) | ||||
| Net Income | (11.57 M) | ||||
| Cash And Equivalents | 8.61 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 3.00 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (9.97 M) | ||||
| Short Ratio | 0.83 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 1.49 | ||||
| Market Capitalization | 10.13 M | ||||
| Total Asset | 2.99 M | ||||
| Retained Earnings | (152.18 M) | ||||
| Working Capital | (2.15 M) | ||||
| Current Asset | 19.48 M | ||||
| Current Liabilities | 330 K | ||||
| Net Asset | 2.99 M |
About BiocardiaInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BiocardiaInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiocardiaInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiocardiaInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BiocardiaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.Moving against BiocardiaInc Stock
| 0.51 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BiocardiaInc Piotroski F Score and BiocardiaInc Altman Z Score analysis. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.88) | Return On Assets (1.14) | Return On Equity (7.04) |
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.